Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma chylomicrons and triglycerides contained in very-low-density lipoproteins. Type V hyperlipoproteinemia is often associated with diabetes mellitus and is not caused by reduced lipoprotein lipase activity as in hyperlipoproteinemia type I.
Features include: Diabetes mellitus, Low HDL ("good") cholesterol (decreased hdl cholesterol concentration), Decreased LDL cholesterol concentration, and Increased VLDL cholesterol concentration and 1 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 3 | Low HDL ("good") cholesterol (decreased hdl cholesterol concentration), Decreased LDL cholesterol concentration, Increased VLDL cholesterol concentration |
Lab test results | 2 | Increased VLDL cholesterol concentration, Increased circulating chylomicron concentration |
Hormones | 1 | Diabetes mellitus |
APOA5 encodes apolipoprotein A5 (366 aa). Minor apolipoprotein mainly associated with HDL and to a lesser extent with VLDL. May also be associated with chylomicrons. Highest expression in Liver (309.2 TPM) and Testis (1.6 TPM).
Hyperlipoproteinemia type V is associated with mutations in the APOA5 gene on chromosome 11.
The APOA5 protein participates in Expression of APOA5, APOA4,APOA5,APOC2,CIDEC,FGF21 genes express APOA4,APOA5,APOC2,CIDEC,FGF21 proteins, and LPL hydrolyses TGs from mature CMs pathways.
APOA5 is classified as a druggable target (Druggable Genome category) with score 1.4.
Genetic testing for APOA5 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE1, 1 NA. Research is sponsored by a mix of industry and academic institutions.
15 publications have been identified in PubMed for hyperlipoproteinemia type V. Research spans Case Report / Case Series (40%), Epidemiology / Natural History (27%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 40% |
Disease patterns and progression | 4 | 27% |
Laboratory research | 2 | 13% |
Research summaries | 1 | 7% |
Clinical study results | 1 | 7% |
New treatment approaches | 1 | 7% |
Ariza MJ (2026). [PMID: 41688327](https://pubmed.ncbi.nlm.nih.gov/41688327/). *Journal of clinical lipidology*. [Case Report / Case Series]
Miyauchi S (2026). [PMID: 41705492](https://pubmed.ncbi.nlm.nih.gov/41705492/). *Endocrinology, diabetes & metabolism case reports*. [Case Report / Case Series]
Guay SP (2025). [PMID: 40664291](https://pubmed.ncbi.nlm.nih.gov/40664291/). *Clinical biochemistry*. [Basic Science / Preclinical]
Merlini S (2025). [PMID: 40346724](https://pubmed.ncbi.nlm.nih.gov/40346724/). *Alzheimer's & dementia : the journal of the Alzheimer's Association*. [Epidemiology / Natural History]
Li F (2025). [PMID: 40535644](https://pubmed.ncbi.nlm.nih.gov/40535644/). *American journal of translational research*. [Gene Therapy / Novel Therapeutics]
Ariza MJ (2025). [PMID: 39873189](https://pubmed.ncbi.nlm.nih.gov/39873189/). *Genetics in medicine : official journal of the American College of Medical Genetics*. [Case Report / Case Series]
Emmert AS (2025). [PMID: 40147599](https://pubmed.ncbi.nlm.nih.gov/40147599/). *Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association*. [Clinical Trial Publication]
Cao C (2024). [PMID: 38462482](https://pubmed.ncbi.nlm.nih.gov/38462482/). *Journal of atherosclerosis and thrombosis*. [Case Report / Case Series]
Moreno Tirado A (2024). [PMID: 38692986](https://pubmed.ncbi.nlm.nih.gov/38692986/). *Medicina clinica*. [Case Report / Case Series]
Heath O (2024). [PMID: 38974610](https://pubmed.ncbi.nlm.nih.gov/38974610/). *JIMD reports*. [Epidemiology / Natural History]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 1:58 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center